IOM Recommendations – NCI Clinical Trials Cooperative Group Program

As NCI begins to respond to the IOM recommendations and other stakeholders' input regarding streamlining the Cooperative Groups, the following resources are available:

Presentation to the Cooperative Group Chairs – View slides of NCI’s initial presentation on transforming the Clinical Trials Cooperative Group Program, which focused on the recommendations regarding consolidation of the adult Cooperative Groups and on integration of the entire Program.

IOM Report – NCI asked the Institute of Medicine (IOM) of the National Academies to review the NCI Clinical Trials Cooperative Group Program in order to gather independent and expert perspectives on the state of cancer clinical trials and to obtain advice about improvements in the NCI Cooperative Group Program. The IOM report was issued in April 2010.

NCI's Progress on IOM Goals and Recommendations – Review the changes and improvements in efficiency that NCI has put in place over the past five years.

Backgrounder and FAQs – Read about NCI's Cooperative Group Program and the Institute’s efforts to transform the clinical trials enterprise, and view the most frequently asked questions about changes in the Cooperative Group Program.

Meetings – View a list of meetings where NCI will be presenting information about addressing the IOM recommendations for Cooperative Groups.

Send a Comment – If you have comments or feedback that you would like NCI to consider as we begin to implement IOM's recommendations to transform the NCI Cooperative Groups, please send an email to NCICGInfo@mail.nih.gov and include your organization affiliation and contact information.